Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 8Anemia 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Neoplasms 7Myelodysplastic Syndromes 7Primary Myelofibrosis 5Myeloproliferative Disorders 5Lymphoma, Follicular 5Leukemia 5Hematologic Neoplasms 5Anemia, Refractory, with Excess of Blasts 5Thrombocytopenia 4Polycythemia Vera 4Lymphoma, Mantle-Cell 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Lymphocytic, Chronic, B-Cell 4Febrile Neutropenia 4Congenital Abnormalities 4Anemia, Sickle Cell 4Anemia, Aplastic 4Thrombocythemia, Essential 3Pdgfra-Associated Chronic Eosinophilic Leukemia 3Lymphoma, Non-Hodgkin 3Lymphoma 3Leukemia, Neutrophilic, Chronic 3Leukemia, Myelomonocytic, Chronic 3Burkitt Lymphoma 3Blast Crisis 3

Interventions

avatrombopag 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Liver Diseases × Classical hematology × Clear all
NCT04437953 2020-12-08

Avatrombopag for Thrombocytopenia in People With Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Withdrawn
Classical hematology

Liver Diseases, Neoplasms, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡